# DESCRIPTION

## FIELD OF THE INVENTION

- relate to compounds

## BACKGROUND OF THE INVENTION

- motivate interferon level increase
- limitations of current treatments

## SUMMARY OF THE INVENTION

- unexpected finding on AMD3100
- define CXCR4 receptor-binding compound
- application of compound for IFN level increase
- application of compound for IFN secretion increase
- application of compound for disease prevention/treatment
- method for IFN level increase
- method for IFN secretion increase
- method for disease prevention/treatment
- in vitro use of compound
- in vitro and in silico screening methods

## DETAILED DESCRIPTION OF THE INVENTION

- define CXCR4 receptor-binding compound

### CXCR4 Receptor-Binding Compound

- define CXCR4 receptor
- describe CXCR4 receptor-binding compound
- determine CXCR4 binding by flow cytometry analysis
- define preferred CXCR4 receptor-binding compound
- describe compound of formula (I)
- define Z and Y in formula (I)
- define A in formula (I)
- define R and R' in formula (I)
- describe preferred compound of formula (I)
- describe compound of formula (II)
- define D₁ and D₂ in formula (II)
- define X in formula (II)
- describe preferred compound of formula (II)
- describe compound of formula (III)
- define E₁, E₂, and E₃ in formula (III)
- describe preferred compound of formula (II)
- describe plerixafor
- describe AMD070
- describe synthesis of compounds of formula (I) and (II)
- describe pharmaceutically acceptable salt and/or hydrate
- define alkyl
- define aryl
- define heteroaryl
- define heteroalkyl
- define alkylaryl
- define arylalkyl
- describe halogen atom
- describe preferred CXCR4 receptor-binding compound
- describe plerixafor and AMD070
- describe synthesis of compounds of formula (I) and (II)
- describe pharmaceutically acceptable salt and/or hydrate
- describe CXCR4 receptor-binding compound
- describe prevention and treatment
- describe interferon
- describe disease or disorder
- describe individual

### In Vitro Screening Methods

- describe in vitro screening method
- describe flow cytometry
- describe blood cells

### In Silico Experiments

- describe in silico method
- describe docking
- describe in silico docking experiments
- describe designed compound or candidate compound

## EXAMPLE

### A. Materials and Methods

- obtain blood samples
- isolate and culture blood leukocytes
- stimulate and infect cells with viruses
- use chemical compounds
- detect cytokines
- perform RT-qPCR analysis
- model CXCR4 with ligands
- perform statistical analysis
- describe experimental procedures
- outline materials used

## RESULTS

### 1. AMD3100 Prevents Type I Interferon Production Inhibition Induced by Amines

- test AMD3100 for inhibition of type I interferon production
- quantify expressions of TRAIL, IFN-a, and IFN-β

### 2. Identification of a Binding Pocket for AMD3100 on CXCR4 Extracellular Domain

- perform in silico docking experiments
- identify binding pockets on CXCR4

